Cigna vs Costco Stock: Which Is Best?
Cigna and Costco don’t usually go hand in hand but…
Buy
93
CART Quote, Financials, Valuation and Earnings
Last price:
$46.31
Seasonality move
:
60.63%
Day range:
$45.05 - $46.66
52-week range:
$23.59 - $50.01
Dividend yield:
0%
P/E ratio:
30.51x
P/S ratio:
4.06x
P/B ratio:
4.17x
Volume:
3.3M
Avg. volume:
4.5M
1-year change:
95.06%
Market cap:
$12B
Revenue:
$3B
EPS (TTM):
$1.53
Analysts' Opinion
-
Consensus RatingMaplebear has received a consensus rating of Hold. The company's average rating is a Hold based on 11 Buy ratings, 14 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $51.05, Maplebear has an estimated upside of 9.59% from its current price of $46.58.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $37.00 representing 20.57% downside risk from its current price of $46.58.
Fair Value
-
According to the consensus of 25 analysts, Maplebear has 9.59% upside to fair value with a price target of $51.05 per share.
CART vs. S&P 500
-
Over the past 5 trading days, Maplebear has overperformed the S&P 500 by 2% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Maplebear does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Maplebear has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Maplebear reported revenues of $852M.
Earnings Growth
-
Maplebear has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Maplebear reported earnings per share of $0.42.
Enterprise value:
10.7B
EV / Invested capital:
--
Price / LTM sales:
4.06x
EV / EBIT:
28.05x
EV / Revenue:
3.23x
PEG ratio (5yr expected):
--
EV / Free cash flow:
15.29x
Price / Operating cash flow:
19.19x
Enterprise value / EBITDA:
24.17x
Gross Profit (TTM):
$2.5B
Return On Assets:
10.47%
Net Income Margin (TTM):
13.46%
Return On Equity:
13.63%
Return On Invested Capital:
13.63%
Operating Margin:
16.2%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | -- | $3B | $3.3B | $764M | $852M | |
| Gross Profit | -- | $2.2B | $2.5B | $561M | $641M | |
| Operating Income | -- | -$2.1B | $380M | -$2.5B | $138M | |
| EBITDA | -- | -$2B | $441M | -$2.4B | $156M | |
| Diluted EPS | -- | -$20.44 | $1.53 | -$20.86 | $0.42 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | -- | -- | $3.1B | $2.5B | |
| Total Assets | -- | -- | -- | $4.4B | $3.9B | |
| Current Liabilities | -- | -- | -- | $683M | $820M | |
| Total Liabilities | -- | -- | -- | $937M | $1.1B | |
| Total Equity | -- | -- | -- | $3.5B | $2.9B | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | $767M | $111M | $185M | |
| Cash From Investing | -- | -- | -$37M | $57M | -$26M | |
| Cash From Financing | -- | -- | -$1.4B | $7M | -$301M | |
| Free Cash Flow | -- | -- | $697M | $95M | $171M | |
CART
Sector
Market Cap
$12B
$310.8M
Price % of 52-Week High
93.14%
71.7%
Dividend Yield
0%
0%
Shareholder Yield
13.69%
2.67%
1-Year Price Total Return
95.06%
-15.07%
Beta (5-Year)
--
0.502
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$44.84
200-day SMA
Buy
Level
$37.99
Bollinger Bands (100)
Buy
Level
38.5 - 45.3
Chaikin Money Flow
Buy
Level
56.8M
20-day SMA
Buy
Level
$43.55
Relative Strength Index (RSI14)
Buy
Level
60.59
ADX Line
Buy
Level
17.99
Williams %R
Sell
Level
-9.7138
50-day SMA
Buy
Level
$43.78
MACD (12, 26)
Buy
Level
0.70
25-day Aroon Oscillator
Buy
Level
84
On Balance Volume
Neutral
Level
121.1M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (3.0427)
Sell
CA Score
(Annual)
Level (-2.7609)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (10)
Sell
Ohlson Score
Level (1.5218)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (7)
Sell
Fundamental Score
Level (4)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Maplebear (Instacart) operates a leading grocery delivery platform in the United States and Canada. The company partners with various regional and national grocers, which offer their selection of food and other goods to customers through Instacart’s ubiquitous platform. Once an item is ordered through Instacart’s site, the item is picked and delivered to the customer’s home by one of the platform’s 600,000 shoppers, who are classified as independent contractors. Instacart earns fees based on average order value and leverages its platform’s high usage to sell advertising, mainly to consumer-packaged goods companies. Instacart currently has about 8 million monthly active users (or orderers) on its platform.
Stock Forecast FAQ
In the current month, CART has received 11 Buy ratings 14 Hold ratings, and 0 Sell ratings. The CART average analyst price target in the past 3 months is $51.05.
-
Where Will Maplebear Stock Be In 1 Year?
According to analysts, the consensus estimate is that Maplebear share price will rise to $51.05 per share over the next 12 months.
-
What Do Analysts Say About Maplebear?
Analysts are divided on their view about Maplebear share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Maplebear is a Sell and believe this share price will drop from its current level to $37.00.
-
What Is Maplebear's Price Target?
The price target for Maplebear over the next 1-year time period is forecast to be $51.05 according to 25 Wall Street analysts, 11 of them rate the stock a Buy, 0 rate the stock a Sell, and 14 analysts rate the stock a Hold.
-
Is CART A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Maplebear is a Hold. 14 of 25 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of CART?
You can purchase shares of Maplebear via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Maplebear shares.
-
What Is The Maplebear Share Price Today?
Maplebear was last trading at $46.31 per share. This represents the most recent stock quote for Maplebear. Yesterday, Maplebear closed at $46.58 per share.
-
How To Buy Maplebear Stock Online?
In order to purchase Maplebear stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will T-Mobile Stock Recover?
Last year was a stellar year for telecom giant T-Mobile…
Why Is Stanley Druckenmiller Buying Citigroup?
As recently as 2020, few analysts could have predicted that…
Stock Ideas
Sell
46
Is AAPL Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 38x
Sell
47
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 112x
Sell
48
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 36x
Alerts
Sell
45
NUTX alert for Jan 17
Nutex Health [NUTX] is up 2.83% over the past day.
Buy
53
QMCO alert for Jan 17
Quantum [QMCO] is down 15.61% over the past day.
Sell
34
NGVT alert for Jan 17
Ingevity [NGVT] is up 1.31% over the past day.
